Bridgeway Capital Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-80,900
| Closed | -$84K | – | 1451 |
|
|
2019
Q1 | $84K | Sell |
80,900
-50,000
| -38% | -$51.9K | ﹤0.01% | 1292 |
|
|
2018
Q4 | $98K | Hold |
130,900
| – | – | ﹤0.01% | 1309 |
|
|
2018
Q3 | $278K | Hold |
130,900
| – | – | ﹤0.01% | 1266 |
|
|
2018
Q2 | $302K | Buy |
130,900
+50,000
| +62% | +$115K | ﹤0.01% | 1249 |
|
|
2018
Q1 | $257K | Hold |
80,900
| – | – | ﹤0.01% | 1234 |
|
|
2017
Q4 | $332K | Sell |
80,900
-8,000
| -9% | -$32.8K | ﹤0.01% | 1192 |
|
|
2017
Q3 | $402K | Buy |
+88,900
| New | +$402K | ﹤0.01% | 1144 |
|